# BRTX — BioRestorative Therapies Inc · catalysts, narrative & risks

**Deep-research report — K3vl4r**  
**Symbols:** BRTX  
**Sources:** 17  
**Published:** 2026-09-02  
**Canonical:** https://app.k3vl4r.com/research/deep-research-brtx-biorestorative-therapies-inc-catalysts-narrative-ri-3050

---

# BioRestorative Therapies Inc. (NASDAQ: BRTX) — Point-in-Time Profile

## Current Snapshot (as of Oct 12–13, 2026)
BioRestorative Therapies, Inc. (Melville, NY; founded 1997; ~14 employees) is a late-stage clinical regenerative-medicine company building cell/tissue-based therapies from adult stem cells across three programs: a disc/spine program (lead candidate BRTX-100), a metabolic program (ThermoStem), and a commercial BioCosmeceutical platform [[1]](https://www.charlottenc.gov/files/sharedassets/city/v/31/streets-and-neighborhoods/parking-and-streets/documents/street-maintenance/utilitycertificationlistbyname.pdf) [[14]](https://biorestorative.com/) [[15]](https://stockanalysis.com/stocks/brtx/).

---

_Preview only. The complete multi-source deep-research report — full thesis, evidence, and citations — is available at https://app.k3vl4r.com/research/deep-research-brtx-biorestorative-therapies-inc-catalysts-narrative-ri-3050 (free to sign up)._